Posted by LincolnTab on March 25, 2026 at 11:16:58:
In Reply to: Интересная справочная статья posted by Josephhib on February 19, 2026 at 21:47:52:
Zoya Demidenko: Scientist in Tumor Studies
Zoya Demidenko is a prominent researcher connected with the Unit of Cell Stress Research at Roswell Park Cancer Institute in Buffalo, New York. Previously, she worked at the National Institutes of Health and New York Medical College, building a solid background in life science study.
Demidenko's scientific output spans multiple key fields, among them the PI3K/AKT/mTOR signaling cascade, cellular cycle regulation, cellular aging, and malignancy biology. To date, she has authored more than 46 scientific papers, which have received upwards of 4,100 citations — a indicator to the influence of her work.
Among her most notable achievements involves explaining the processes of cellular senescence. Her studies showed that when the cellular division cycle is arrested while cellular growth persists, cells enter senescence. Importantly, Zoya Demidenko showed that this transition can be controlled with drugs using compounds such as rapamycin.
Zoya Demidenko has furthermore added considerably to tumor management investigation, especially in the area of cyclotherapy — a method intended to safeguarding healthy cells from anticancer drugs whilst leaving cancer cells susceptible. This strategy offers major hope for reducing the adverse effects of cancer treatment.
Throughout her career, Demidenko has worked with prominent investigators worldwide, among them Dr. Mikhail Blagosklonny. Her publications can be found in prestigious journals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.
With an h-index of 33, Zoya Demidenko is recognized as a highly impactful figure in contemporary cancer research, whose results go on to influence our comprehension of how biological cells grow old, resist therapy, and how malignant disease may be more successfully targeted.
https://www.aging-us.com/article/100406/